A constant voltage charge, therefore, allows detection of this voltage increase and thus control of the current charge amount.
#PDC TO DIRECT DC ADAPTOR FULL#
As the battery reaches full charge, the positive plate begins generating dioxide causing a sudden rise in voltage due to decreasing internal resistance. After some time, however, it should level off.ĭuring charge, the lead sulfate of the positive plate becomes lead dioxide. Depending on the state of charge (SoC), the cell may temporarily be lower after discharge than the applied voltage. To charge a sealed lead acid battery, a DC voltage between 2.30 volts per cell (float) and 2.45 volts per cell (fast) is applied to the terminals of the battery. To obtain maximum battery service life and capacity, along with acceptable recharge time and economy, constant voltage-current limited charging is best. Sealed lead acid batteries may be charged by using any of the following charging techniques:
#PDC TO DIRECT DC ADAPTOR SERIES#
This means we recommend using a sealed lead acid battery charger, like the the A-C series of SLA chargers from Power Sonic, when charging a sealed lead acid battery. Power Sonic recommends you select a charger designed for the chemistry of your battery. The selection of a suitable SLA battery charger and the methods used to charge it is just as important as choosing the right battery for the application. Following incorrect charging procedures or using inadequate charging equipment can result in decreased battery life and/or poor battery performance. Data shown are representative of 3 independent experiments.Dependable performance and long service life of your sealed lead acid battery will depend upon correct battery charging. In (C), supernatants were collected from the MLRs described in (B) and assayed for IL-10 by ELISA. Numbers represent mean percentages ± 1SD of live CD4 + Foxp3 + cells from 3 independent experiments. Cells were collected and stained for CD4 and intracellular Foxp3. In (B), B6 WT BM-pDC were either pretreated with anti-ICOSL mAb or rat IgG (isotype control) (10 μg/ml) for 30 min before their use as stimulators of bulk BALB/c T cells for 72h (1 pDC:4 T cells). Anti-ICOSL or control (10 μg/ml) was added to pDC prior to the start of MLR cultures (1 pDC:4 T cells). Alternatively, immature or CpG-activated (act) B6 pDC were used to stimulate 10 5 allogeneic BALB/c T cells directly (right). (A) Purified WT pDC were pulsed overnight with cell-free BALB/c (H2 d) splenocyte lysate, then stimulated with CpG or left unstimulated before culture with 10 5 syngeneic normal T cells (indirect pathway left). These findings implicate ICOSL-induced IL-10, but not IDO in the regulation of BM-derived pDC function. Moreover, when ICOSL was blocked on WT pDC, T-cell proliferation resembled that induced by IDO KO pDC, and interleukin (IL)-10 secretion in MLR was markedly decreased.
Compared with WT pDC, activated IDO KO DC expressed much lower levels of ICOSL. DAP12 silencing increased the T-cell stimulatory capacity of WT pDC, but only in the presence of 1-MT. The DNAX-activating protein of 12 kDa (DAP12), which inhibits functional IDO expression, was expressed in BM-pDC. Although IDO KO pDC induced enhanced T-cell responses compared with WT pDC, the use of the IDO inhibitor 1-methyltryptophan (1-MT) demonstrated that the inferior stimulatory capacity of WT pDC was not caused by the production of functional IDO, even under IDO-inducing conditions. In some experiments, pDC were first activated by exposure to CpG +/- CTLA4Ig for IDO induction via B7 ligation. pDC generated from BM of wild-type (WT) or IDO knockout (KO) C57BL/6 mice were used to stimulate T-cell proliferation and interferon-gamma (IFN-gamma) production in response to alloantigen (alloAg) via the direct or indirect pathways. We investigated the role of two key immunoregulatory molecules, indoleamine dioxygenase (IDO) and inducible costimulator ligand (ICOSL), in determining the function of bone marrow (BM)-derived plasmacytoid (p)DC, which offer the potential for therapy of allograft rejection.
0 kommentar(er)
